New cholesterol drug shows promise for taiwanese patients
NCT ID NCT06925100
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 34 times
Summary
This study tested a cholesterol-lowering drug called bempedoic acid in 180 adults in Taiwan who have high cholesterol or mixed lipid problems. The goal was to see how well it lowers bad cholesterol (LDL-C) and if it is safe. Participants either could not reach their LDL-C goals with statins or could not take statins at all. The results will help doctors understand if this drug works well for the Taiwanese population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Far Eastern Memorial Hospital
New Taipei City, 220, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 807, Taiwan
-
Linkou Chang Gung Memorial Hospital
Taoyuan, 333, Taiwan
Conditions
Explore the condition pages connected to this study.